In research and development, your cell lines are among your most valuable assets. Yet the journey from qualification to long-term storage is often fragmented. Samples are frequently transferred between laboratories for testing and off-site storage facilities, introducing unnecessary risk at a critical stage of the research lifecycle. Safeguarding your assets shouldn’t be a logistical challenge. That’s why, at Biofortuna, we
Safe and compliant storage is crucial when working with Genetically Modified Organisms (GMOs). By outsourcing storage, organisations can free up laboratory space, reduce operational burden and focus on advancing their research. However, your choice of storage partner has a direct impact on regulatory compliance, sample safety and the success of your project, making it vital to select a provider you
High quality reagents are the cornerstone of research and development. However, the logistics behind supporting researchers to access critical, high-quality reagents, like cell lines, in a timely manner can often be overwhelming, especially post-Brexit. There multiple challenges to overcome in sample management: managing the risk of non-compliance, overhead costs and long distribution timelines while maintaining sample integrity. This is where
Human biological samples are one of the most valuable resources when it comes to the progression of scientific research. Whether these samples are DNA, blood or tissue, they hold the answers needed to understand disease and unlock new therapies. As a result, the ability to correctly access, store and retrieve disease relevant human samples is an essential, yet often challenging,
In life sciences, every sample has the potential to drive discoveries, critical diagnoses and vital therapeutic advancements. But without the proper care of these samples, even the most promising research can become flawed. At Biofortuna, we understand that safeguarding materials, be they biological specimens or reagents, is not just about storage. Instead, it’s about protecting your investment, timelines and the